±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 152  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

zhantian3529

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

[½»Á÷] ¡¾×ªÌû¡¿Illuminating Anesthetic Targets

A photoreactive analog of a common inhaled anesthetic might shed light on the targets and binding sites of these promiscuous drugs. Volatility and low binding affinities plague efforts to pin down molecular targets for inhaled anesthetics such as isoflurane and sevoflurane, which are used every day in operating rooms worldwide. One way to get around those drawbacks is to synthesize versions of anesthetics with light-reactive moieties. However, current analogs have some disadvantages: They aren¡¯t exact mimics of known anesthetics, or they contain photoreactive groups that preferentially react with certain amino acids, potentially biasing the probes toward some binding sites and not others. Now, anesthesiologist Roderic G. Eckenhoff of the University of Pennsylvania School of Medicine and a multi-institution team have developed azi-isoflurane, a photoreactive mimic of isoflurane that has neither of those drawbacks (ACS Chem. Neurosci., DOI: 10.1021/cn900014m). Azi-isoflurane binds in known isoflurane binding pockets in two model proteins and is a more potent anesthetic than isoflurane in vivo. The team hopes to use azi-isoflurane to identify molecular targets underlying both the desirable and undesirable effects of isoflurane.


Chemical & Engineering News
ISSN 0009-2347
Copyright © 2009 American Chemical Society
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wu3833145

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¹§Ï²ÇÀɳ·¢£¬¸ø¸öºì°ü
ѧϰѧϰ£¬¸Ðл·ÖÏí
2Â¥2009-10-30 14:28:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ccq19

Òø³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.2):ÇÀÁ˸öС°åµÊ£¬¸ø¸öºì°ü
¿´µ½´ó¶ÎÓ¢ÎÄÎÒ¾ÍÍ·ÌÛ
ÄãÒ»¼ú£¬ÎÒ¾ÍЦ
3Â¥2009-10-30 15:05:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zhantian3529 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ѹ¹ú¼ÒÒ»ÇøÏߣ¬Çóµ¼Ê¦ÊÕÁô£¬Óж÷±ØÐ»£¡ +3 ÃÔÈ˵Ĺþ¹þ 2026-03-28 3/150 2026-03-28 07:34 by ACS Nano¡ª¡ª
[¿¼ÑÐ] 085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á +10 ·³ÕСç÷ 2026-03-27 10/500 2026-03-28 03:36 by fmesaito
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸ÄÏÅ©083200ʳƷ¿ÆÑ§Ó빤³Ì +5 XQTJZ 2026-03-26 5/250 2026-03-27 14:49 by ¿ñìÅÂóµ±µ±
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤ 264·Ö¸÷¿Æ¹ýAÇø¹ú¼ÒÏß +10 ¹þ¹þ157349 2026-03-21 10/500 2026-03-27 13:06 by zzll406
[¿¼ÑÐ] 276Çóµ÷¼Á¡£ÓаëÄêµç³ØºÍ°ëÄê¸ß·Ö×Óʵϰ¾­Àú +10 ²ÄÁÏѧ257Çóµ÷¼Á 2026-03-23 11/550 2026-03-27 10:13 by YCIT- LHL
[¿¼ÑÐ] 304²ÄÁÏÇóµ÷¼Á +4 ÖÓllll 2026-03-26 4/200 2026-03-27 03:42 by wxiongid
[¿¼ÑÐ] Çóµ÷¼Á +8 Auroracx 2026-03-22 8/400 2026-03-26 19:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 340Çóµ÷¼Á +3 Amber00 2026-03-26 3/150 2026-03-26 18:57 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 281Çóµ÷¼Á +6 Koxui 2026-03-24 7/350 2026-03-26 15:37 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 296Çóµ÷¼Á +4 Íô£¡£¿£¡ 2026-03-25 7/350 2026-03-25 16:41 by Íô£¡£¿£¡
[¿¼ÑÐ] ¡¾2026¿¼Ñе÷¼Á¡¿ÖÆÒ©¹¤³Ì 284·Ö ÇóÏà¹Ø×¨Òµµ÷¼ÁÃû¶î +4 Ô¬Û¼Û¼ 2026-03-25 8/400 2026-03-25 14:32 by lbsjt
[¿¼ÑÐ] ¸÷λÀÏʦÄúºÃ£º±¾È˳õÊÔ372·Ö +5 jjÓ¿77 2026-03-25 6/300 2026-03-25 14:15 by mapenggao
[¿¼ÑÐ] 293Çóµ÷¼Á +7 ¼ÓÒ»Ò»¾Å 2026-03-24 7/350 2026-03-25 12:02 by userper
[¿¼ÑÐ] »¯Ñ§µ÷¼Á +6 yzysaa 2026-03-21 6/300 2026-03-25 09:27 by aa331100
[¿¼ÑÐ] ʳƷר˶ һ־Ը˫һÁ÷ 328 +3 xiaom99 2026-03-21 4/200 2026-03-24 21:20 by lailaisimei
[¿¼ÑÐ] 300·Ö£¬²ÄÁÏ£¬Çóµ÷¼Á£¬Ó¢Ò»Êý¶þ +5 ³¬ÔÞµÄ 2026-03-24 5/250 2026-03-24 21:07 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +7 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 7/350 2026-03-24 20:26 by peike
[¿¼ÑÐ] 305·ÖÇóµ÷¼Á£¨Ê³Æ·¹¤³Ì£© +5 Sxy112 2026-03-21 7/350 2026-03-24 12:27 by 544594351
[¿¼ÑÐ] »·¾³Ñ§Ë¶288Çóµ÷¼Á +8 ƤƤƤ123456 2026-03-22 8/400 2026-03-23 23:47 by ÈÈÇéɳĮ
[¿¼ÑÐ] 341Çóµ÷¼Á(Ò»Ö¾Ô¸ºþÄÏ´óѧ070300) +5 ·¬ÇÑÍ·--- 2026-03-22 6/300 2026-03-23 23:45 by Txy@872106
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û